Stocks in Focus

Record Quarterly Earnings and Raised Price Target… APR Up 6% [Featured Stock]

Kwon Oh Seok
2026-08-06 09:33:48
[Edaily Reporter Kwon Oh Seok ] APR(278470)’s stock price is showing strength in early trading. It appears that buying interest is surging following the company’s record-breaking quarterly earnings and positive outlooks from securities analysts.
(Photo: APR)

According to MP Doctor on the 6th, APR’s stock is trading at 374,500 won as of 9:25 a.m., up 6.29% from the previous trading day.
The previous day, APR announced in a preliminary earnings release that it recorded consolidated revenue of 767.5 billion won and operating profit of 190.6 billion won for the second quarter of 2026. These figures represent year-over-year increases of 134.2% and 134.5%, respectively, with an operating profit margin of 24.8%.
APR explained that, driven by rapid global growth, it simultaneously set new records for both quarterly revenue and operating profit—the highest since its founding—and achieved its best-ever performance. In particular, the company achieved top-tier performance in the beauty industry, fueled by the expansion of its overseas business—centered on North America and Europe—and the strengthening of its brand competitiveness.
Driven by this growth, cumulative revenue for the first half of this year reached 1.3609 trillion won, marking the company’s best-ever half-year performance. This figure is on par with last year’s annual revenue (1.5273 trillion won).
The company attributed the strong first-half performance to the global growth of its cosmetics and beauty business division. The division posted revenue of 648.3 billion won—an increase of 185.5% compared to the same period last year—marking its best-ever quarterly performance. It maintained triple-digit growth driven by its expansion into global markets, the expansion of online and offline channels, and the broadening of its product portfolio.
Securities firms are also unanimously raising their target prices. HANWHA INVESTMENT & SECURITIES raised its target from 500,000 won to 550,000 won, while EUGENE INVESTMENT & SECURITIES raised its target from 510,000 won to 530,000 won.

Economy

Corporation

IT·Science

Economy

[VC's Pick] Big Money Flows into Smart 'Medical AI and Robotics' Technologies That Replace Human Hands

This week (November 16–20), startups in various fields—including robotics, image analysis, and business platforms—secured investments from venture capital (VC) firms and accelerators (ACs). In particu…
2026-11-21 10:04:03

Corporation

Celltrion Sees Full-Scale Results from Direct Sales in the U.S. … “Projected Operating Profit of 2.4 Trillion Won Next Year”

Celltrion(068270)Forecasts indicate that Celltrion will continue its steep earnings growth as it expands its direct sales performance in the U.S. biosimilar market. Expectations for a revaluation of t…
2026-11-21 06:01:02

IT·Science

Penetrium Bioscience and AprilBio Rally as AriBio-Linked Stocks Diverge [K-Bio Pulse]

South Korean pharmaceutical and biotechnology stocks posted mixed results on November 19, driven by clinical trial developments and expectations regarding their inclusion in major stock indices. Penet…
2026-11-21 08:17:02